Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e336e8f1c646b5e4212c9675d7f9d629 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-26 |
filingDate |
2013-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daaa6d9030c2a05fb072249e4c9bc1c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e4073b3aced6bafa493fb0a96feb349 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d87050611423b417fa2728aa6fb349d4 |
publicationDate |
2015-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2872487-A1 |
titleOfInvention |
Process for making isoquinoline compounds |
abstract |
The present invention relates to methods for making isoquinoline compounds and the intermediate compounds achieved thereby. Such compounds can be used to prepare compounds and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF). |
priorityDate |
2012-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |